ABVC BioPharma, Inc. (ABVC)
0.8444
-0.08
(-8.22%)
USD |
NASDAQ |
Aug 24, 16:00
0.8444
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Total Liabilities (Quarterly) : 7.131M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.131M |
| March 31, 2026 | 6.904M |
| December 31, 2025 | 7.765M |
| September 30, 2025 | 6.719M |
| June 30, 2025 | 6.751M |
| March 31, 2025 | 6.919M |
| December 31, 2024 | 6.816M |
| September 30, 2024 | 6.484M |
| June 30, 2024 | 6.805M |
| March 31, 2024 | 6.973M |
| December 31, 2023 | 6.531M |
| September 30, 2023 | 7.530M |
| June 30, 2023 | 9.687M |
| March 31, 2023 | 9.000M |
| December 31, 2022 | 6.343M |
| September 30, 2022 | 4.787M |
| June 30, 2022 | 4.602M |
| March 31, 2022 | 4.705M |
| December 31, 2021 | |
| September 30, 2021 | 4.765M |
| June 30, 2021 | 8.429M |
| March 31, 2021 | 8.797M |
| December 31, 2020 | 8.945M |
| September 30, 2020 | 7.721M |
| June 30, 2020 | 7.876M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.838M |
| December 31, 2019 | 7.053M |
| September 30, 2019 | 6.675M |
| June 30, 2019 | 10.28M |
| March 31, 2019 | 12.98M |
| December 31, 2018 | 11.28M |
| September 30, 2018 | 5.043M |
| June 30, 2018 | 4.887M |
| March 31, 2018 | 4.489M |
| December 31, 2017 | 4.400M |
| September 30, 2017 | 4.148M |
| June 30, 2017 | 1.056M |
| December 31, 2016 | 6.538M |
| September 30, 2016 | 6.556M |
| June 30, 2016 | 8.561M |
| March 31, 2016 | 10.01M |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0392M |
| June 30, 2015 | 0.0374M |
| March 31, 2015 | 0.0359M |
| December 31, 2014 | 0.0351M |
| September 30, 2014 | 0.034M |
| June 30, 2014 | 2.112M |
| March 31, 2014 | 2.112M |
| December 31, 2013 | 2.112M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| Perspective Therapeutics, Inc. | 68.16M |
| MiMedx Group, Inc. | 65.00M |
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.40M |
| Shareholders Equity (Quarterly) | 10.29M |
| Debt to Equity Ratio | 0.2807 |
| Current Ratio | 0.0723 |
| Net Debt Paydown Yield | 0.05% |